ArticleEye (London, England)2026
Dropless cataract surgery: comparing sub-Tenon's and topical steroids for postoperative inflammation prophylaxis.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment on: Dropless cataract surgery: comparing sub-Tenon's and topical steroids for postoperative inflammation prophylaxis.Eye (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesTo compare sub-Tenon's ("dropless") and topical steroid regimens for inflammation prophylaxis following cataract surgery. SUBJECTS/
methodsThis retrospective cohort study was conducted using the electronic health record (EHR) of a single academic medical centre in Philadelphia, Pennsylvania, USA. All patients who underwent phacoemulsification cataract surgeries from January 1, 2023, to August 31, 2024 were analysed. Eyes in the dropless group received an intraoperative sub-Tenon's triamcinolone acetonide (TA) injection. Eyes in the topical group followed a routine postoperative topical steroid taper (prednisolone acetate 1% drops). Baseline characteristics included age, race, and relevant comorbidities. Key outcomes assessed were incidence of intraocular pressure (IOP) spikes greater than 35 mmHg, cystoid macular oedema (CMO), and rebound iritis. Differences were analysed with Fisher's exact tests and linear regressions.
resultsA total of 3307 eyes were included (291 treated with the dropless protocol and 3016 with topical drops). Baseline patient characteristics were similar between groups in terms of age, sex, and comorbidities, with the exception that the dropless cohort had a higher proportion of Black patients (46.0% vs 34.4%, p < 0.01) and diabetic patients (40.5% vs. 30.9%, p < 0.01). There were no significant differences between dropless and topical groups in the incidence of IOP spikes >35 mmHg, CMO, or rebound iritis (all p > 0.05).
conclusionsSub-Tenon's TA was noninferior to topical steroids in terms of incidence of IOP spikes, CMO, and rebound iritis following cataract surgery. However, further research is needed to identify risk factors for adverse outcomes and determine ideal use cases for a dropless protocol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.